Blood Research

Download original image

Table 1 Characteristics of patients with inadequate response to eculizumab.

a)At the time additional prednisolone was started. b)Reference range: 23.0–46.0 U/mL. c)Reference range: 50–200 ng/mL. d)Reference range: 3.7–31.5 mIU/mL. e)CD55-negative cells/CD59-negative cells.

Abbreviations: CI, cerebral infarction; CKD, chronic kidney disease; LDH, lactate dehydrogenase; NT, not tested; Pd, low-dose prednisolone treatment (5 mg/day); RPI, red cell production index.

Blood Res 2017;52:337~339 https://doi.org/10.5045/br.2017.52.4.337
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd